We reported that cannabidiolic acid (CBDA), a non-psychotropic constituent of fiber-type cannabis plants, down-regulates the mRNA expression of cyclooxygenase-2 (COX-2) in highly aggressive MDA-MB-231 human breast cancer cells. However, the molecular mechanism(s) underlying the CBDA suppression of COX-2 have not yet been elucidated in detail. In MDA-MB-231 cells, COX-2 expression is known to be tightly regulated by the transcriptional activity of activator protein-1 (AP-1), which is composed of a heterodimer of c-Fos and c-Jun. AP-1-mediated transcriptional activity was inhibited by CBDA in a dose-dependent manner. The expression of c-fos was maintained at markedly lower levels (0.035) than basal c-jun expression levels (1.0), implicating cfos as a limiting factor in the regulation of COX-2. Analyses indicated that CBDA abrogated the expression of c-fos mRNA without affecting c-jun. Collectively, these results suggest that CBDA abolishes the expression of COX-2 by interfering with AP-1 activity in MDA-MB-231 cells.
The transcription factor activator protein-1 (AP-1) complex regulates many genes involved in the regulation of physiological activities such as cellular proliferation, transformation, and death [1] . The AP-1 complex is composed of homo-or heterodimers of the Jun and Fos families of transcription factors [1] . In contrast to c-Fos, c-Jun may also form a homodimer (c-Jun/c-Jun) in cells. However, when c-Fos and c-Jun are co-expressed in cells, they preferably form a heterodimer (the AP-1 complex) [2] .
We reported that i) cannabidiolic acid (CBDA) (Figure 1 , inset) inhibits the enzymatic activity of cyclooxygenase-2 (COX-2), an enzyme involved in inflammatory processes and in the metastasis of cancer cells, with an IC 50 value of 2.2 M [3] , and ii) CBDA diminishes the expression of COX-2 in human breast cancer MDA-MB-231 cells [4] . Furthermore, CBDA has been shown to abrogate the migration of MDA-MB-231 cells [5, 6] . MDA-MB-231 cells were established as a breast cancer in vitro model for preclinical studies because these cells exhibit a highly aggressive nature in vitro and in vivo [7] . Transcriptional factors such as AP-1 and NF-B may be involved in the regulation of the COX-2 gene [8] [9] [10] ; when focusing on the regulation of COX-2 in MDA-MB-231 cells, the importance of the c-Fos/c-Jun (AP-1) complex has been demonstrated [11] .
We herein describe the mechanisms underlying the regulation of CBDA in COX-2 gene expression by focusing on AP-1-mediated transcriptional activity in MDA-MB-231 cells. We show that i) CBDA down-regulated the expression of c-fos without affecting that of c-jun, and ii) AP-1-driven transcriptional activity was abrogated by CBDA in a concentration-dependent manner.
We analyzed the effects of CBDA on the viability of MDA-MB-231 cells. As shown in Figure 1 , cell viability was not influenced by CBDA concentrations up to 25 M (1, 2.5, 5, 10, 15, and 25 M); however, cells started to die at concentrations greater 50 M (IC 50 value = 37.05 M). In accordance with the above results, changes in cell morphology were only detected at 50 M CBDA (data not shown).
Since COX-2 gene expression in MDA-MB-231 cells is tightly regulated by AP-1, which is composed of the c-Fos/c-Jun heterodimer [11] (Figure 2 We searched consensus sequences for response elements to transcription factors within the promoter region of the human COX-2 gene. In addition to response elements (AP-1) for the AP-1 complex, elements showing homology to putative PPAR response elements (PPREs) for PPAR were found in the gene 5'-flanking region. Based on these results, we investigated the effects of CBDA on AP-1 transcriptional activity. When measuring peroxisome proliferator-activated receptors (PPARs)/PPRE-driven transcriptional activities in MDA-MB-231 cells that express functional PPARs [13] , "no" observable modulating effects on PPRE-mediated transcriptional activity were detected ( Figure 4A ). Importantly, we observed for the first time that CBDA exerted inhibitory effects on AP-1-mediated transcriptional activity in a concentration-dependent manner ( Figure 4B ).
In conclusion, the results of the present study indicate that CBDA abolishes c-fos expression, coupled with reductions in AP-1 transcriptional activity as well as decreases in COX-2 expression in MDA-MB-231 cells.
Experimental
Materials and cell culture: CBDA was isolated from fiber-type cannabis leaves according to established methods (purity: >98%) [3] , and a commercially available CBDA sample (purity: 96.5%) was also used (Sigma-Aldrich, St. Louis, MO, USA). No significant differences were observed in the biological activity of either CBDA sample. All other reagents were of analytical grade, commercially available, and used without further purification. Cell culture (human breast cancer MDA-MB-231 cells) conditions and methods were based on previously described procedures [4] [5] [6] 12] . Briefly, the MDA-MB-231 cell line was routinely grown in phenol redcontaining minimum essential medium  (MEM) (Wako Pure Chemical Industries, Osaka, Japan), supplemented with 10 mM HEPES [4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid], 5% fetal bovine serum, 100 U/ml of penicillin, and 100 g/mL of streptomycin at 37ºC in a 5% CO 2 -95% air-humidified incubator. Prior to the 24 h chemical treatments, medium was changed to phenol red-free MEM (Wako Pure Chemical Industries) supplemented with 10 mM HEPES, 5% dextran-coated charcoaltreated serum, 100 U/ml of penicillin, and 100 g/ml of streptomycin. The chemicals used in this study were prepared in ethanol. Control incubations contained equivalent additions of ethanol.
Cell morphology studies:
In morphological examinations of the cell line MDA-MB-231, images were obtained using a Leica DMIL inverted microscope (Leica Microsystems, Wetzlar, Germany), and captured with a Pixera ® Penguin 600CL Cooled CCD digital camera (Pixera Co., Los Gatos, CA, USA). Data were processed using Pixera Viewfinder 3.0 software (Pixera Co.). Three areas with approximately equal cell densities were identified in each well and images of each of these areas were captured.
Cell viability analysis:
In the viability experiment, MDA-MB-231 cells were seeded on 96-well plates at a density of 5,000 cells/well, and CBDA was introduced 4 h after plating. After a 48 h incubation, cell viability was analyzed using the CellTiter Glo COX-2 were utilized based on previous studies [13] [14] [15] . COX-2, cjun, and c-fos mRNA levels were normalized to -actin mRNA levels.
Transfection and luciferase reporter assay (dual-luciferase assay):
Twenty-four hours prior to transfection, MDA-MB-231 cells were seeded (5 × 10 4 cells/well) on 24-well plates containing MEM. The transfection of each expression plasmid was performed using Lipofectamine ® LTX with PLUS TM reagent (Thermo Fisher Scientific) according to the manufacturer's instructions. DNA mixtures containing 300 ng of the PPRE-Luc plasmid with the rat acyl-CoA oxidase PPRE (a gift from Dr. Curtis J. Omiecinski, Pennsylvania State University, PA, USA) [15] or pGL4.44 [luc2P/AP1 RE/Hygro] vector for AP-1 (Promega) were cotransfected with 2 ng of the Renilla luciferase reporter plasmid (pRL-CMV) in the plates. Cells were washed with phosphatebuffered saline 24 h post-transfection and changed to phenol redfree MEM supplemented with 5% dextran-coated charcoal-treated serum, followed by the respective chemical treatments being tested. Cell extracts were then prepared using 100 L of passive lysis buffer (Promega), and 20 L was then applied to the firefly luciferase and Renilla luciferase assays (Dual-Luciferase Reporter Assay System, Promega). The ratio of firefly luciferase activity (expressed from reporter plasmids) to Renilla luciferase activity (expressed from pRL-CMV) in each sample served as a measure of normalized luciferase activity.
Data analysis: Differences were considered significant when the P value was calculated to be less than 0.05. Differences between two independent groups were calculated using the Student's t-test. A data analysis of differences among multiple groups was calculated using Dunnett's test. These calculations were performed using Statview 5.0J software (SAS Institute Inc., Cary, NC, USA).
